|Bid||1.8100 x 0|
|Ask||1.8400 x 0|
|Day's Range||1.7900 - 1.8600|
|52 Week Range||0.1800 - 2.5000|
|Beta (5Y Monthly)||2.06|
|PE Ratio (TTM)||151.67|
|Earnings Date||Feb. 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Delivers first 700V, 300kWh battery system for an electric busTORONTO, ON / ACCESSWIRE / March 17, 2021 / Electrovaya Inc. (TSX:EFL)(OTCQB:EFLVF) (the "Company") is pleased to announce the launch of its electric bus lithium ion battery systems with the delivery of a 700V, 300kWh battery.
24, 2021 /CNW/ - The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, is announcing today that the first patient has been dosed and imaged in a Phase 3 trial for [18F]PSMA-1007. This diagnostic imaging product is a positron-emitting tomography (PET) agent that targets Prostate Specific Membrane Antigen (PSMA), a protein that is overexpressed in prostate cancer.
TORONTO, ON / ACCESSWIRE / February 23, 2021 / Electrovaya Inc. ("Electrovaya" or the "Company") (TSX:EFL)(OTCQB:EFLVF), a lithium ion battery manufacturer with industry-leading performance and substantial intellectual property, has submitted an initial application to list its common shares on the Nasdaq Stock Market ("NASDAQ").